Artículos por temáticas

Does the M.D. Anderson Dysphagia Inventory correlate with dysphagia-limit and the Unified Parkinson Disease Rating Scale in early-stage Parkinson's disease?

Wang CM, Tsai TT, Wang SH, Wu YR.

J Formos Med Assoc. 2020 Jan;119(1 Pt 2):247-253. doi: 10.1016/j.jfma.2019.05.005. Epub 2019 May 24.

Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.

Hopfner F, Wod M, Höglinger GU, Blaabjerg M, Rösler TW, Kuhlenbäumer G, Christensen K, Deuschl G, Pottegård A.

Neurology. 2019 May 24. pii: 10.1212/WNL.0000000000007694. doi: 10.1212/WNL.0000000000007694. [Epub ahead of print]

Safety and efficacy of Rotigotine in hospedalized patients with Vascular Parkinsonism aged 75 and older: effects on movement, praxis capacities, time-space orientation, quality of life and adherence to medical therapy.

Marchitto N, Sindona F, Pannozzi A, Dalmaso SG, Anticoli S, Raimondi G.

Acta Biomed. 2019 May 23;90(2):248-250. doi: 10.23750/abm.v90i2.6945.

Apelin-13 attenuates motor impairments and prevents the changes in synaptic plasticity- related molecules in the striatum of Parkinsonism rats.

Haghparast E, Sheibani V, Abbasnejad M, Esmaeili-Mahani S.

Peptides. 2019 May 20. pii: S0196-9781(19)30063-4. doi: 10.1016/j.peptides.2019.05.003. [Epub ahead of print]

Drug treatment strategies for depression in Parkinson disease.

Ryan M, Eatmon CV, Slevin JT.

Expert Opin Pharmacother. 2019 May 23:1-13. doi: 10.1080/14656566.2019.1612877. [Epub ahead of print]

DNAJC proteins and pathways to parkinsonism.

Roosen DA, Blauwendraat C, Cookson MR, Lewis PA.

FEBS J. 2019 May 23. doi: 10.1111/febs.14936. [Epub ahead of print] Review.

Gait and postural disorders in parkinsonism: a clinical approach

Raccagni C, Nonnekes J, Bloem BR, Peball M, Boehme C, Seppi K, Wenning GK.

J Neurol. 2020 Nov;267(11):3169-3176. doi: 10.1007/s00415-019-09382-1. Epub 2019 May 22.

Bipolar disorder and risk of Parkinson disease: A nationwide longitudinal study.

Huang MH, Cheng CM, Huang KL, Hsu JW, Bai YM, Su TP, Li CT, Tsai SJ, Lin WC, Chen TJ, Chen MH.

Neurology. 2019 May 22. pii: 10.1212/WNL.0000000000007649. doi: 10.1212/WNL.0000000000007649. [Epub ahead of print]

X-Linked Dystonia-Parkinsonism: recent advances.

Bragg DC, Sharma N, Ozelius LJ.

Curr Opin Neurol. 2019 May 20. doi: 10.1097/WCO.0000000000000708. [Epub ahead of print]

Is High-Spatial-Resolution Diffusion MRI Applicable for the Diagnosis of Parkinson Disease?

Sung YH, Kim EY.

Radiology. 2019 May 21:190486. doi: 10.1148/radiol.2019190486. [Epub ahead of print] No abstract available.

Early- vs late-start levodopa relieved symptoms but did not affect disease progression in Parkinson disease.

Friedman JH.

Ann Intern Med. 2019 May 21;170(10):JC56. doi: 10.7326/ACPJ201905210-056. No abstract available.

Video-based assessments of the hind limb stepping in a mouse model of hemi-parkinsonism

Ogawa M, Zhou Y, Tsuji R, Goto S, Kasahara J.

Neurosci Res. 2020 May;154:56-59. doi: 10.1016/j.neures.2019.05.002. Epub 2019 May 16.

Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson disease.

Giannini G, Francois M, Lhommée E, Polosan M, Schmitt E, Fraix V, Castrioto A, Ardouin C, Bichon A, Pollak P, Benabid AL, Seigneuret E, Chabardes S, Wack M, Krack P, Moro E.

Neurology. 2019 May 17. pii: 10.1212/WNL.0000000000007665. doi: 10.1212/WNL.0000000000007665. [Epub ahead of print]

Parkinsonism and dysautonomia: Multiple system atrophy?

Albanese A, Cocco A, Milani P, Lalli S, Palladini G.

Parkinsonism Relat Disord. 2019 May 3. pii: S1353-8020(19)30226-3. doi: 10.1016/j.parkreldis.2019.05.005. [Epub ahead of print] No abstract available.

Substantia nigra hyperechogenicity in essential tremor and Parkinson disease: a longitudinal study.

Cardaioli G, Ripandelli F, Paolini Paoletti F, Nigro P, Simoni S, Brahimi E, Romoli M, Filidei M, Eusebi P, Calabresi P, Tambasco N.

Eur J Neurol. 2019 May 16. doi: 10.1111/ene.13988. [Epub ahead of print]